Description
The Novel Coronavirus (SARS-Cov-2) Antigen Rapid Detection Device (saliva) is an in vitro diagnostic test used to qualitatively detect the novel coronavirus antigen in human saliva using rapid immunochromatography. Identification is based on monoclonal antibodies that are specific for novel coronavirus antigens. It will provide clinicians with information to prescribe the right medications.
- Diagnostic reagent in vitro
- rapid detection of antigens
Production Capacity:
1000000
Delivery Timeframe:
Immediate
Incoterms:
CIF - Cost, Insurance and Freight
FOB - Free on Board
Packaging Details:
Not informed
More about
Hangzhou Realy Tech Co., Ltd
200-500
Employees
1
Sales volume (USD)
90%
% Export sales
Year
Established
Business type
- Industry / Manufacturer
Keywords
- Diagnostic reagents in vitro
Contact and location
- Joe Pan
- +86 xxxxxxxx
- 杭州 / | China